Articles in Type 2 Diabetes
Study on fatty liver (MASLD) care in Europe: how ready are health systems for new models of care?
By Liver & Heart Team
Ten European countries compared: how fatty liver is managed today and what new care models need.
Review on early detection of liver scarring in fatty liver: new tests and better models of care
By Liver & Heart Team
Which tests detect liver scarring in fatty liver early, and how better cooperation between specialties can improve care.
EASL expert guidance on fatty liver (SLD): who gets tested where, and who treats how?
By Liver & Heart Team
How family doctors, metabolic clinics and liver specialists should work together on fatty liver: EASL recommendations.
Expert consensus for primary care: assessing and treating heart, kidney, liver and metabolic health together (CKLMS, fatty liver/MASLD)
By Liver & Heart Team
How family doctors can check heart, kidney, liver and metabolism together with simple tests: recommendations from an expert group.
Study on health policy on fatty liver (MASLD/MASH) in Europe: how well prepared are the countries?
By Liver & Heart Team
No national strategy in 28 countries: what a new analysis shows about how prepared Europe is for fatty liver.
Review of new treatment approaches for MASH (fatty liver inflammation): which drugs exist and who do they help?
By Liver & Heart Team
Resmetirom, semaglutide and other drugs: what a new review shows about treating fatty liver inflammation.
Review of care pathways for fatty liver (MASLD): how dangerous liver scarring is found early
By Liver & Heart Team
Nine studies with 8,551 people show that simple tests find liver scarring early, but only about half of those referred reach the specialist.